Adults with established cardiovascular disease and overweight or obesity without diabetes now have an FDA-approved indication for Wegovy (semaglutide 2.4 mg) to reduce the risk of cardiovascular death, heart attack, and stroke, based on the SELECT trial results
Stacking considerations and cautions While the theoretical rationale for stacking is sound, it is important to acknowledge that very few studies have examined specific multi-peptide combinations for bone healing
In a substudy of the phase 2 obesity trial, researchers measured liver fat using MRI-PDFF, a precise imaging method, in participants who started with elevated liver fat of at least 10%
Semax increases BDNF Brain-Derived Neurotrophic Factor which supports cognitive function, neuroplasticity, and mental sharpness
With injectible GLP-1s, local reactions like itchiness or redness may occur at the injection site